Global Cord Blood Corp
OTC:CORBF

Watchlist Manager
Global Cord Blood Corp Logo
Global Cord Blood Corp
OTC:CORBF
Watchlist
Price: 0.95 USD Market Closed
Market Cap: 127.2m USD

Net Margin

280.7%
Current
No historical data
Comparison unavailable

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
280.7%
=
Net Income
¥501.1m
/
Revenue
¥1.2B

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
280.7%
=
Net Income
$501.1m
/
Revenue
¥1.2B

Peer Comparison

Country Company Market Cap Net
Margin
HK
Global Cord Blood Corp
OTC:CORBF
115.5m USD
Loading...
US
CVS Health Corp
NYSE:CVS
101.5B USD
Loading...
US
Cigna Corp
NYSE:CI
72.6B USD
Loading...
US
Cigna Group
XMUN:CGN
62B EUR
Loading...
DE
Fresenius SE & Co KGaA
XETRA:FRE
26.6B EUR
Loading...
DE
Fresenius Medical Care AG
XMUN:FME
21.3B EUR
Loading...
US
Laboratory Corporation of America Holdings
NYSE:LH
22.8B USD
Loading...
US
Quest Diagnostics Inc
NYSE:DGX
21.2B USD
Loading...
US
Guardant Health Inc
NASDAQ:GH
14.1B USD
Loading...
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
10.5B EUR
Loading...
AU
Sonic Healthcare Ltd
ASX:SHL
11.2B AUD
Loading...
No Stocks Found

Market Distribution

Higher than 97% of companies in Hong Kong
Percentile
97th
Based on 3 006 companies
97th percentile
280.7%
Low
-239 513 300% — -12.9%
Typical Range
-12.9% — 5.3%
High
5.3% — 203 056%
Distribution Statistics
Hong Kong
Min -239 513 300%
30th Percentile -12.9%
Median 0.5%
70th Percentile 5.3%
Max 203 056%

Global Cord Blood Corp
Glance View

Market Cap
127.2m USD
Industry
Health Care

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. The company employs 1,215 full-time employees The company went IPO on 2009-11-19. The firm and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. The company provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. The company also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The firm provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. The company also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.

CORBF Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
280.7%
=
Net Income
¥501.1m
/
Revenue
¥1.2B
How has Net Margin changed over time?

Over the last 3 years, Global Cord Blood Corp’s Net Margin has increased from 198% to 280.7%. During this period, it reached a low of 198% on Mar 3, 2019 and a high of 287.2% on Mar 31, 2021.

Back to Top